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SUMMARY
Increases in protein levels of XIAP in cancer cells have been associated with resistance to apoptosis induced
by cellular stress. Herein we demonstrate that the upregulation of XIAP protein levels is regulated byMDM2 at
the translational level. MDM2 was found to physically interact with the IRES of the XIAP 50-UTR, and to posi-
tively regulate XIAP IRES activity. This XIAP IRES-dependent translation was significantly increased in
MDM2-transfected cells where MDM2 accumulated in the cytoplasm. Cellular stress and DNA damage trig-
gered by irradiation induced the dephosphorylation and cytoplasmic localization of MDM2, which also led to
an increase in IRES-dependent XIAP translation. Upregulation of XIAP in MDM2-overexpressing cancer cells
in response to irradiation resulted in resistance of these cells to radiation-induced apoptosis.INTRODUCTION
Inhibitor-of-apoptosis proteins (IAP) form a family of caspase
inhibitors that block the downstream portion of the apoptosis
pathway and inhibit cell death in response to multiple stimuli.
There are currently eight known human IAP family members,
and XIAP is a very important inhibitor of apoptosis among these
members (Schimmer, 2004; Eckelman et al., 2006). XIAP has
been shown to bind specifically to and inhibit caspases 3, 7,
and 9, but not the remaining caspases (Riedl et al., 2001; Shio-
zaki et al., 2003). The distinct cascades of caspase activation
regulate different apoptosis pathways that can be triggered via
intrinsic and extrinsic signals (Green, 2005). For example, activa-
tion of caspase-9 initiates the intrinsic (mitochondrial) pathway of
apoptosis, which is the major mechanism involved in cell death
induced by cellular stress and DNA damage, such as from
exposure to ultraviolet irradiation (UV) and ionizing radiation
(IR) (Kuida et al., 1998). Activation of caspases 3 and 7 are distal
steps in this intrinsic apoptosis pathway (Lakhani et al., 2006).
The specific inhibition of these caspases by XIAP suggests
that XIAP is a molecule that is critical for regulating sensitivity
to apoptosis induced by cellular stress and DNA damage.Previous studies have demonstrated that the expression of
XIAP mRNA in most tissues and cells is fairly consistent (Liston
et al., 1996). Cellular stresses such as exposure to IR will induce
alteration of XIAP protein expression, without concomitant
changes in XIAP mRNA levels, in a variety of cancer cells (Holcik
et al., 1999). These observations suggest that the expression of
XIAP is mainly regulated at the translational level. Initiation of
translation can occur by two distinct mechanisms, cap-depen-
dent scanning and internal ribosome entry. The lattermechanism
requires an internal ribosome entry segment (IRES) located in
the 50 untranslated region (UTR) of the mRNA and the interaction
of IRES trans-acting factor (ITAF)/ribonucleoprotein (RNP)
(Stoneley and Willis, 2004). So far, IRES elements have been
found mainly in mRNAs involved in regulating gene expression
during development, differentiation, cell growth, and survival
(Bonnal et al., 2003). In particular, IRES of certain antiapoptotic
genes become activated under conditions where cap-depen-
dent protein synthesis is greatly reduced, such as upon cellular
stress and DNA damage; thus, activated IRES initiates transla-
tion of proteins that can protect cells from stress (Komar and
Hatzoglou, 2005). It is known that XIAP translation is uniquely
regulated by the IRES mechanism. There is a 162-nucleotide (nt)SIGNIFICANCE
Overexpression of the MDM2 oncoprotein, which is often found in cancer cells, is associated with resistance to chemora-
diation therapy and poor prognosis of cancer patients. MDM2 is well characterized as an inhibitor of the tumor suppressor
p53, and overexpression of MDM2 contributes to a growth advantage for cancer cells. However, the mechanism by
which overexpression of MDM2 confers resistance to DNA damage induced by irradiation and chemotherapy is not fully
elucidated. We report here that MDM2 was able to bind to XIAP mRNA and positively regulate the IRES-dependent XIAP
translation during cellular stress triggered by irradiation. These results identify a p53-independent function for MDM2 in
mediating XIAP translation, which is critical in effecting cancer cell response to chemoradiation therapy.Cancer Cell 15, 363–375, May 5, 2009 ª2009 Elsevier Inc. 363
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MDM2 Regulates XIAP in Cancer CellsIRES sequence in the 50-UTR of XIAP mRNA (Holcik et al., 1999).
Three ITAFs/RNPs, namely La, hnRNP C1/C2, and hnRNP A1,
have been identified as able to regulate XIAP IRES activity
(Holcik and Korneluk, 2000; Holcik et al., 2003; Lewis et al.,
2007). Reports show that IRES-regulated XIAP translation is acti-
vated in cancer cells in response to IR, and that upregulation of
XIAP results in increased resistance to apoptosis induced by this
stress stimulation (Holcik et al., 2000; Lewis and Holcik, 2005).
The MDM2 protein is a multifunctional oncoprotein, and its
ability to inactivate the p53 function through interaction with
this tumor suppressor has been well characterized. In addition
to interacting with and regulating p53, it has been demonstrated
that MDM2 interacts with other molecules including specific
protein and RNA, which might play a p53-independent role in
oncogenesis. For example, MDM2 was shown to bind to and
ubiquitinate Rb, resulting in Rb degradation and release of the
E2F1 that promotes cell cycle progression (Xiao et al., 1995).
MDM2 was also found to bind E2F1 directly, and to enhance
E2F1 stability (Zhang et al., 2005). The C-terminal RING finger
domain of MDM2 was found to exhibit specific RNA binding
ability. A SELEX (systematic evolution of ligands by exponential
enrichment) procedure yielded a subset of RNA molecules that
bind efficiently to MDM2 in vitro (Elenbaas et al., 1996).
Aside from regulating other cellular molecules, MDM2 itself is
modulated by various cellular signals. Phosphorylation and
subcellular distribution of MDM2 is regulated by the PI3K/Akt
pathway (Mayo and Donner, 2001). Cell growth/survival factor-
induced activation of PI3K and its downstream target Akt will
phosphorylate cytoplasmic MDM2 on serines 166 and 186.
Phosphorylation of these sites is required for translocation of
MDM2 from the cytoplasm into the nucleus. In contrast to
survival signals that induce MDM2 phosphorylation, cellular
stress and DNA damage invoke dephosphorylation of MDM2
(Meek and Knippschild, 2003; Blattner et al., 2002). It has been
shown that dephosphorylation of the central acidic domain of
MDM2 is essential for accumulation and stabilization of p53 in
stressed wild-type (wt) p53 cells. Stress also induces signaling
for dephosphorylation of MDM2 at serine 166 (Okamoto et al.,
2002), which might lead to inhibition of nuclear entry of MDM2
or an increase in its translocation from the nucleus to the cyto-
plasm. Once MDM2 is released from p53 and is localized in
the cytoplasm, it could play a p53-independent role. Because
MDM2 is able to bind RNA and shuttles between the nucleus
and the cytoplasm, which are the properties of most ITAFs/
RNPs, we hypothesize that the dephosphorylated cytoplasmic
MDM2 might act as an ITAF/RNP to exhibit a p53-independent
role in regulating translation through binding of its C terminus
to specific RNA.
We have previously demonstrated a link between MDM2 and
XIAP. In a study utilizing transfection of MDM2 into a p53-null
leukemia cell line, we found that the expression of XIAP protein
is upregulated in the MDM2-transfected cells (Gu et al., 2002).
Because the expression of XIAP is primarily regulated at the
translational level though the IRES-dependent mechanism, we
have now investigated the possible regulation of XIAP translation
by MDM2 and the mechanism by which MDM2 acts as an ITAF/
RNP to regulate XIAP IRES activity. Furthermore, we investi-
gated the impact of MDM2-mediated XIAP expression on irradi-
ation-induced apoptosis in human cancer cells.364 Cancer Cell 15, 363–375, May 5, 2009 ª2009 Elsevier Inc.RESULTS
IR Induces MDM2 Modulation and XIAP Translation
It is known that IR treatment dephosphorylates MDM2. To test
whether IR-induced dephosphorylated MDM2 becomes disso-
ciated from the MDM2-p53 complex and translocated from
the nucleus to the cytoplasm, we examined the cellular redistri-
bution of MDM2 and its association with p53 following IR
treatment in an acute lymphoblastic leukemia (ALL) cell line
EU-1. This cell line was chosen for the test because EU-1 cells
have a wt p53 and overexpress MDM2 (Figure S1A, available
online), and MDM2 is predominantly localized in the nucleus
of cultured/untreated cells (Zhou et al., 2003). As is shown
in Figure 1A, IR treatment decreased nuclear MDM2 and
increased cytoplasmic MDM2 expression, and induced down-
regulation of MDM2 at serine 166 in EU-1 cells. IP western
blot analysis demonstrated that MDM2 dissociated from p53
after IR treatment, as shown in Figure 1B, in which the levels
of both MDM2 and p53 in immunocomplexed form precipitated
with p53 and MDM2 antibodies, respectively, were significantly
reduced in the IR-treated cells as compared with untreated
cells.
We next evaluated whether there was concomitant upregula-
tion of XIAP expression that would occur at a translational level,
following the IR-induced cytoplasmic translocation of MDM2.
We began by testing whether IR directly induces XIAP mRNA
expression. Consistent with previous observation in other cancer
cells (Holcik et al., 1999), XIAP mRNA was not induced by IR in
EU-1 cell line (Figure 1C). The stability of XIAP mRNA was also
not affected by IR treatment. As shown in Figure 1D, there
was no difference in degradation rate of XIAP mRNA between
IR-treated and untreated EU-1 cells. We next evaluated the
effect of IR on XIAP translation in the MDM2-overexpressing
cells. We treated EU-1 cells with IR in the presence or absence
of the protein synthesis inhibitor cycloheximide (CHX). In the
absence of CHX, IR induced XIAP, whereas XIAP was not
induced by the same exposure of IR in the presence of CHX
(Figure 1E). In order to directly demonstrate an increase in
XIAP translation after IR in EU-1 cells, we further performed
metabolic [35S]-methionine labeling and IP analysis. As shown
in Figure 1F, a significant increase inmetabolically labeled, newly
synthesized XIAP was apparent in the IR-treated cells, whereas
the total XIAP protein levels were found to be equivalent in
untreated versus IR-treated cells in the presence of the protea-
some inhibitor MG132. In addition, we performed linear sucrose
gradient fractionation to assess the polyribosome association
of the XIAP mRNA in EU-1 cells subjected to IR and mock
treatment. We found that XIAP mRNA was clearly shifted from
fractions containing translation dormant complexes including
mRNPs, ribosome subunits, and monosomes (Figure 1G,
bottom, fractions 1–4) to fractions enriched of translating polyri-
bosomes (Figure 1G, bottom, fractions 5–11), indicative of
enhanced translation. Consistent with a previous observation
(Lu¨ et al., 2006), IR treatment had no effect on the polyribosome
profile of actinmRNA (Figure 1G, top). Furthermore, therewas no
appreciable difference in XIAP protein stability between EU-1
cells exposed to IR and those without IR exposure (Figure 1H),
thus demonstrating that induction of XIAP by IR occurs at the
translational level.
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MDM2 Regulates XIAP in Cancer CellsFigure 1. Modulation of MDM2 and XIAP Translation by IR
(A) EU-1 cells were treated with 10 Gy IR for different times as indicated, and cell extracts were tested for the nuclear (Nuc) and cytoplasmic (Cyt) expression of
MDM2 as well as for total MDM2 and MDM2 phosphorylation at site 166 in whole cell extract (WCE) in western blot assays.
(B) Cell lysates fromEU-1 treatedwith or without 10Gy IR for 4 hr were IPwith antibodies as indicated. Normalmouse antibody served as control (Con). Proteins in
immune complexes were detected by western blotting.
(C) mRNA expression of XIAP after treatment with 10 Gy IR for the indicated time in EU-1 cells was determined by quantitative RT-PCR. Data represents themean
(±SD) levels of XIAP mRNA of three independent experiments.
(D) EU-1 cells were treated with 10 Gy IR for 2 hr followed by addition of 5 mg/ml actinomycin D. At different times after actinomycin D addition, the cells were
harvested, and total RNA was isolated. The amount of XIAP mRNA remaining was determined by northern blotting and quantified by densitometric analysis.
Labels under bands in the blot represent XIAP mRNA levels after normalization to actin, compared with samples (0, defined as 1 unit).
(E) EU-1 cells were treated with and without 10 mg/ml CHX for 10 min, before 10 Gy IR. Extracts from cells that were unirradiated (0) or harvested 1 or 2 hr after IR
were assessed for expression of XIAP, to show that CHX blocked IR-induced XIAP.
(F) XIAP protein was IP from EU-1 cells that had been labeled for 5 min with [35S]-methionine, 30 min after 0 or 10 Gy IR, and then assessed by autoradiography
(upper panel). Cells that had been pretreated with 50 mMMG132 and analyzed by western blot showed equivalent amounts of XIAP in the IP as a control for total
XIAP protein that was not turnover in unirradiated versus irradiated cells (middle panel). Controls include analysis of whole cell extracts (WCE), where equal
amounts of [35S]-methionine incorporated into the irradiated and unirradiated cells (bottom panel).
(G) IR enhances association of the XIAPmRNAwith translating polyribosomes. EU-1 cells were treated with or without 10 Gy IR for 12 hr, and cytoplasmic lysates
were fractionated on sucrose gradient. RNA was extracted from each of the fractions and subjected to quantitative RT-PCR for quantitative analysis of the distri-
bution of XIAP and Actin mRNAs. Data represent percentage of the total amount of corresponding mRNA on each fraction.
(H) Turnover of XIAP protein in IR-treated and control cells, as detected by pulse-chase assay. EU-1 cells were treatedwith or without 10Gy IR for 2 hr followed by
[35S]methionine labeling. At selected times as indicated after labeling cell lysates were collected for determination of the XIAP 35S protein levels by SDS-PAGE
analysis.Cytoplasmic MDM2 Does Not Regulate XIAP
Transcription and Posttranslational Modification
We considered the possibility that the cytoplasmic translocation
of MDM2 was responsible for induction of XIAP. Because
MDM2 in cultured/unstressed cells is phosphorylated and
located in the nucleus if the cells have a high level of PI3k/Akt acti-
vation, we designed an experiment using gene transfection of an
MDM2plasmid producing anMDM2with amutation at serine166
substitutedwith alanine (MDM2/166A). ThisMDM2with a serine-to-alanine substitution cannot be phosphorylated by PI3K/Akt;
thus, it remains in the cytoplasm (Mayo and Donner, 2001). In
this manner we were able to test the effect of cytoplasmic
MDM2 on XIAP expression. First, we checked the subcellular
distribution of the mutant MDM2 protein in a p53-null ALL cell
line, EU-4 (Figure S1A), by transfecting it with the MDM2/166A
plasmid tagged by red fluorescence protein (pDsRed1-C1). The
red fluorophores indicated that approximately 50% of MDM2/
166A was expressed in the cytoplasm (Figure 2A). A control, theCancer Cell 15, 363–375, May 5, 2009 ª2009 Elsevier Inc. 365
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MDM2 Regulates XIAP in Cancer CellsFigure 2. Effect of Cytoplasmic MDM2 on XIAP Transcription, Translation, and Posttranslational Modification
(A) Subcellular distribution of transfected MDM2/166A and MDM2/166E, as demonstrated by the red fluorophores in EU-4 cells characterized by confocal
microscopy. Scale bars, 10 mm.
(B, C) Expression of transfected MDM2 and XIAP in both MDM2-transfected and control cells were detected by western blot assay (B), and their mRNA levels
were detected by northern blot assay (C).
(D) Quantitative RT-PCR analysis of the MDM2/166A-induced translation enhancement of XIAP mRNA. SH-SY5Y cells were transfected with MDM2/166A and
control plasmid (vehicle), and cytoplasmic extracts were subjected to linear sucrose gradient fractionation. RNA was extracted from each of the fractions and
quantitatively analyzed to evaluate polyribosome association by the XIAP and Actin mRNA.
(E) Turnover of XIAP protein in MDM2/166A-transfected and control cells, as detected by pulse-chase assay. The radioactive labeled XIAP protein levels were
quantified by densitometric analysis. All values were corrected relative to the load control and labeled under bands in the blot compared with samples (0, defined
as 1 unit).mutant MDM2 protein in EU-4 cells transfected with plasmid
MDM2/166E where serine 166 is mutated to glutamic acid that
mimics phosphorylated MDM2 (Mayo and Donner, 2001), was
predominantly localized in the nucleus.
Transfection of MDM2/166A in EU-4 cells upregulated endog-
enous XIAP protein expression (Figure 2B). In contrast, transfec-
tion of MDM2/166E did not upregulate XIAP. To investigate
whether the enhanced XIAP expression seen in MDM2/166A-
transfected cells is due to increased transcription of the XIAP
gene, we performed a northern blot assay. Expression of XIAP
mRNA was not increased in the MDM2/166A-transfected cells
(Figure 2C). We next performed polyribosome profiling assay
to directly evaluate the influence of MDM2/166A on translation
of XIAP in a NB cell line, SH-SY5Y, which expresses a low level
of MDM2 (Figure S1A). Transfection of MDM2/166A resulted in
a shift of XIAP mRNA from translationally inactive complexes to
polyribosomes engaged in active translation (Figure 2D), similar
to that observed in IR-treated EU-1 cells (Figure 1G). Further-
more, we performed pulse-chase experiments using metabolic
[35S]-methionine labeling and IP assay, to evaluate whether the
observed induced XIAP expression in MDM2/166A-transfected366 Cancer Cell 15, 363–375, May 5, 2009 ª2009 Elsevier Inc.cellsmight also involve aposttranslationalmechanism. As shown
inFigure 2E, the half-life of theXIAPprotein inMDM2/166A-trans-
fected cells did not changeas comparedwith that of control cells.
These results suggest that MDM2/166A-upregulated expression
of XIAP most likely occurs only at the translational level.
Cytoplasmic MDM2 Induces XIAP IRES Activity
To test the possible role of cytoplasmic MDM2 in regulating XIAP
translation via an IRES-dependent mechanism, the status of the
50-UTR of XIAP mRNA containing IRES in cancer cells must first
be characterized. The 50-UTR of XIAPmRNA has been controver-
sial inpreviousstudies.Listonetal. (1996) reported that the50-UTR
ofXIAPmRNA isshort (128bp),whereas the50-UTRofXIAPmRNA
reported by Holcik et al. (1999) is long (1.6 or 1.7 kb)
containing a 162 bp IRES sequence (Figure S2A). To clarify this
discrepancy regarding the 50-UTR of XIAP mRNA, we searched
the Human Genome to obtain the entire human XIAP gene
sequence (accession number: AY886519). We have identified a
DNA sequence for the putative promoter region of the XIAP gene
located immediately upstream of the short 50-UTR (Figure S2B).
Importantly, we found that the long 50-UTR of XIAP mRNA is
Cancer Cell
MDM2 Regulates XIAP in Cancer CellsFigure 3. Effect of Cytoplasmic MDM2 on XIAP IRES Activity
(A) Schematic illustration of the monocistronic plasmids and bicistronic plasmids used for the reporter assays.
(B) Transfected MDM2/166A induces XIAP IRES (xi) but not XIAP promoter (xp) activity. Here, 5 mg pGL3-xp or pGL3-xp-xi plasmids were cotransfected with
10 mg MDM2/166A, respectively, into EU-4 cells; then luciferase activities were detected. Cells were cotransfected with the pGL3-basic vector and MDM2/
166A as controls. Other controls include cotransfection of MDM2/166A with plasmids pGL3-xp-xi(r): insertion of the xi into pGL3-xp in a reverse orientation;
and pGL3-xp-xi(-i): insertion of the xi with deletion of the core RNP binding sequence. In addition, the controls were cotransfected with each luciferase plasmid
and with the pcDNA empty vector (vehicle). Data represent the mean and standard deviation (±SD) of three independent experiments normalized to Renilla
luciferase activity (cotransfection of pRL-SV40 vector as control).
(C) Dose-dependent induction of xi-mediated translation of CAT by MDM2/166A in transfection using the bicistronic plasmid pbgal-xi-CAT. EU-4 cells were
cotransfected with 5 mg pbgal-xi-CAT and with increasing amounts (2.5, 5, and 10 mg) of the MDM2/166A (bars 2–4) or vehicle only (bar 1), and 10 mg MDM2-
166E (bar 5). After 24 hr, cell extracts were prepared and the bgal and CAT activities were determined. The bgal and CAT activities in the control reactions
were set at 100%. Bars represent the mean ± SD of three independent experiments. The titrations of MDM2 in cellular extracts from MDM2/166A-transfected
cells and expression of the endogenous XIAP in these cells were detected by western blot assay (insert).
(D) Cotransfection and IRES activity assay for the effect of MDM2 siRNA on xi-mediated translation. LA1-55N cells were cotransfected with 5 mg pbgal-xi-CAT
and different amounts (5 and 10 mg) of three pSUPER MDM2 plasmids (siRNA 1–3). Transfection and CAT/bgal activity assays were performed as described in
(C). CAT (IRES) activity represents the mean percentage (±SD) of control (cotransfection of bgal-xi-CAT with vehicle, not shown) in at least three independent
experiments.a variant that retains a part of intron 1 as a cryptic exon (Figure
S2C). We performed reverse-transcriptase polymerase chain
reaction (RT-PCR) on both ALL and NB cells, searching for the
presence of the short and long versions of the 50-UTR of XIAP,
and found that all the cancer cells studied expressed both
the short and long 50-UTR of XIAP mRNA (Figure S2D). Further
RT-PCR analysis with various controls (DNase digestion of RNA
and absence of reverse transcriptase) confirmed that the long
50-UTR of XIAP containing IRES was indeed an mRNA (exon),
but not genomic DNA (intron) (Figure S2E).
We performed gene transfection and reporter assays using
EU-4 cells and bothmonocistronic and bicistronic plasmids con-
taining the 162 bp XIAP IRES from the long 50-UTR of XIAP.
Results from experiments using the monocistronic plasmids
(Figure 3A), which is driven by the XIAP promoter (xp), showedthat insertion of the XIAP IRES (xi) into a pGL3-xp plasmid regu-
lated luciferase translation, as demonstrated in Figure 3B, where
the luciferase activity of pGL3-xp-xi was found to be only slightly
reduced as compared to that of pGL3-xp (comparison of black
bars in bar 3 versus bar 2). As is also shown in Figure 3B, insertion
of thexi directly into thepGL3basicvector [pGL3-xi] resulted inno
luciferase activity (bar 4), suggesting that a cryptic promoter is not
present in the XIAP IRES. In addition, both insertion of the xi into
pGL3-xp in a reverse orientation (pGL3-xp-xi[r]) and insertion of
the xi with a deletion of the core RNP binding sequence (pGL3-
xp-xi[-i]) abolished XIAP promoter-driven luciferase activity
(bars 5 and6), suggesting that the162bpXIAP IRES is indeedcrit-
ical for proper regulation of luciferase translation. Insertion of the
128 bp short 50-UTR of XIAP into the monocistronic plasmid did
not regulate luciferase activity (data not shown).Cancer Cell 15, 363–375, May 5, 2009 ª2009 Elsevier Inc. 367
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MDM2 Regulates XIAP in Cancer CellsFigure 4. MDM2 Protein Binds to XIAP IRES
(A) Cell extracts from SH-EP1 and SH-SY5Y were
incubated with 32P-labeled RNA probes corre-
sponding to the complete XIAP IRES element
(probe 1) and non-IRES upstream 50-UTR segment
(probe 2) as a control; then UV crosslinked, run on
anSDS-PAGEgel, and imagedbyautoradiography.
RNP-RNA complexes are indicated by arrows.
(B) Cell extracts from SH-EP1 were prepared in
RNA-binding buffer in the presence of RNase
inhibitor (RNasin). Following coimmunoprecipita-
tion with anti-MDM2, anti-La (positive control),
and anti-actin (negative control), the XIAP mRNA
was detected by RT-PCR analysis. IP without
addition of RNasin and antibody and with anti-
MDM2 but no RNasin were done as additional
controls. The positive (SH-EP1 RNA as template,
lane 7) and negative (no template, lane 8) controls
for RT-PCR are also shown.
(C) Recombinant human MDM2 (rhMDM2) protein
binds to XIAP IRES RNA in vitro. The rhMDM2
and rhBcl-2 as an unrelated recombinant
control protein were incubated, respectively, with
32P-labeled RNA probes 1 and 2 (as described
in A), and with a RNA probe (probe 3), clone A
from the SELEX procedure carried out by Elenbaas
etal. (1996), servingaspositivecontrol. Theprotein/
RNA complexes were UV crosslinked, run on an
SDS-PAGE gel, and imaged by autoradiography.
The rhMDM2 were also incubated with probes
without UV exposure as additional controls.
(D) Cell extracts from SH-EP1 were incubated with probe 1 and probe 2, UV crosslinked, and then immunoprecipitated with antibodies (anti-La and
serum as controls) as indicated. Controls also included the absence of UV crosslinking with MDM2 antibody.Cotransfection of either wt MDM2 (data not shown) or MDM2/
166A did not induce XIAP promoter activity (comparison of red
bar with black bar in bar 2 of Figure 3B), which is consistent
with the finding in Figure 2C that shows there was no XIAP
mRNA induction in MDM2/166A-transfected cells. Interestingly,
cotransfection of MDM2/166A significantly enhanced the XIAP
IRES-mediated luciferase activity (comparison of red bar with
black bar in bar 3). This MDM2-stimulated XIAP IRES function
was confirmed in a reporter assay using the bicistronic plasmid
pbgal-xi-CAT (Figure 3A). As shown in Figure 3C, MDM2/166A
significantly increased the activity of CAT (XIAP IRES) but not
the activity of bgal, a control cistron, translation of which is initi-
ated by cap-dependent mechanism. In addition, transfected
MDM2/166A also increased a dose-dependent expression of
endogenous XIAP (Figure 3C, insert). We also found that the
MDM2/166E mutation slightly activated XIAP IRES (Figure 3C),
whereas wt MDM2 induced XIAP IRES activity depending on
the status of PI3K/Akt activation in the cells used for transfection
assays (data not shown).
To further confirm that MDM2 acts as an activator to regulate
XIAP IRES activity, we performed experiments to knockdown
endogenous MDM2 by siRNA to evaluate whether inhibition of
MDM2 results in decreased XIAP IRES activity. We generated
three pSUPER/MDM2 plasmids containing different 19 nt siRNA
sequences specific for targeting MDM2. Transfection of these
plasmids into LA1-55N, aNB cell line withMDM2overexpression
(Figure S1A), significantly suppressed the endogenous MDM2
expression (see below in Figure 6F). Cotransfection of these
MDM2 siRNA plasmids with the pbgal-xi-CAT reporter plasmid368 Cancer Cell 15, 363–375, May 5, 2009 ª2009 Elsevier Inc.into LA1-55N cells remarkably decreased the activity of CAT
(Figure 3D).
In addition, we performed translation assay to evaluate the
effectofMDM2onXIAP IRESactivity using thedicistronicplasmid
pFL-xi-FL.Previousstudieshave shown that thepresenceofXIAP
IRES in pRL-FL vector decreases RL activity in cells transfected
with this plasmid due to spurious splicing within the XIAP IRES,
resulting in a relative increase of FL activity (Van Eden et al.,
2004; Holcik et al., 2005). In agreement with this observation,
transfection of pRL-xi-FL in EU-4 cells decreased the RL activity
as compared with the transfection of pRL-FL (Figure S3A).
However the presence of MDM2 did not affect the RL activity as
compared with the transfection in the absence of MDM2, and
MDM2 increased FL (XIAP IRES) activity (Figure S3A). Consistent
with these results, an in vitro translation assay using pRL-xi-FL
plasmid (with the T7 promoter) and TnT T7 Quick Coupled Tran-
scription/Translation System demonstrated that MDM2 induced
FL (XIAP IRES) activity, but did not affect RL activity (Figure S3B).
MDM2 Physically Interacts with XIAP IRES Both
In Vivo and In Vitro
Because MDM2 could induce XIAP IRES activity, we evaluated
whether MDM2 interacts physically with the XIAP IRES. We per-
formedUV crosslinking of 32P-labeled XIAP IRES probes and cell
extracts from the MDM2-overexpressing NB line SH-EP1
(Figure S1A) and SH-SY5Y to evaluate whether RNP was bound
to the XIAP IRES. Similar results to previous experiments (Holcik
et al., 2000) were obtained, as shown in Figure 4A, in which four
major sizes of RNP (indicated by arrows) bound to the RNA
Cancer Cell
MDM2 Regulates XIAP in Cancer CellsFigure 5. The C-Terminal RING Domain of
MDM2 Binds to the Core RNP Binding
Sequence of XIAP IRES
(A) GST-fused full-length MDM2 (lane 1) and
different GST-fused MDM2 fragments of the
C-terminal RING domain (lanes 2–5) and the frag-
ment with deletion of C-terminal RING domain
(lane 6) were incubated with 32P-labeled XIAP
IRES (probe 1 in Figure 5); the formation of
MDM2 XIAP IRES complexes was detected as
described in Figure 5C.
(B) UV crosslinking and binding assay similar to (A)
for the interaction between XIAP IRES and GST-
fused wt (lane 1) and different mutant (lanes 2–4)
C-terminal RING domains of MDM2: MDM2 (415–
491 D1) with a S428G mutation, MDM2 (415–491
D2) with a G448S mutation, MDM2 (415–491 D3)
with a L487S mutation.
(C) Mapping the MDM2-binding site within XIAP
IRES. Nucleotide sequence of the 162 nt XIAP
IRES (probe 1 as described in Figure 5A) and the
positions of antisense (A1–A10) used for binding
site mapping are shown under the sequence. The
first codon (AUG) is bold.
(D) Antisense mapping of the XIAP IRES/MDM2
binding site. Indicated antisense oligonucleotides
were annealed to probe 1, then incubated with
full-length rhMDM2 and UV crosslinked. The
MDM2/XIAP IRES complex was analyzed as
described in Figure 5C.
(E) Similar antisense mapping of binding within
XIAP IRES to the 415–491 fragment containing
the C-terminal RING domain of MDM2 protein.probe of XIAP IRES. Interestingly, we observed a great reduction
in the density of the high-molecular-size band in the non-MDM2-
overexpressing SH-SY5Y cells as compared with MDM2-over-
expressing SH-EP1 cells (see lanes 2 and 1 in Figure 4A), which
implied that MDM2 might be a component of the RNP complex
formed on the XIAP IRES. Next, we performed IP and RT-PCR
to search for a possible association in vivo between the MDM2
protein and the XIAP mRNA. As shown in Figure 4B, the MDM2
protein was able to bind XIAP mRNA under these conditions as
well. In addition, UV crosslinking and gel electrophoresis showed
that the MDM2 protein strongly bound to the XIAP IRES RNA
in vitro (Figure 4C, lane 3). MDM2 did not bind to the non-IRES
upstream 50-UTR of XIAP (Figure 4C, lane 6). Consistent with a
previous report (Elenbaas et al., 1996), MDM2 bound to a RNA
molecule (clone A) from the SELEX procedure (Figure 4C, lane 9).
As a control, the nonrelated recombinant protein Bcl-2 did not
bind to XIAP IRES. The binding of MDM2 to XIAP IRES was
further confirmed by similar UV crosslinking and gel electropho-
resis using cellular extract of SH-EP1 cells and IP with anti-
MDM2 antibody (Figure 4D).
The C-Terminal RING Domain of MDM2 Binds
to the Core RNP Binding Sequence of XIAP IRES
We performed UV crosslinking and gel electrophoresis to screen
for the domain of MDM2 required for XIAP IRES binding. Fusion
proteins of glutathione S-transferase (GST) and full-length
MDM2, or MDM2 with different deletions (415–491), (425–491),
(434–491), and (425–480), as well as (1–424), were constructedand expressed in Escherichia coli. A subsequent RNA binding
assay revealed that the C-terminal RING domain (425–491) but
not other parts of MDM2 protein (1–424) was able to bind to
XIAP IRES (Figure 5A). We found that the fragments (415–491)
and (425–491) were similar to the full-length MDM2 binding to
XIAP IRES. However, the binding of fragment (434–491) to the
XIAP IRES was greatly reduced, suggesting that 10 amino acids
(425–434) are critical for proper binding. In addition, when the
last 11 hydrophobic amino acids were deleted, the binding of
this fragment (425–480) to XIAP IRES was abolished, suggesting
that these last 11 amino acids are also important for binding to
the XIAP IRES.
Other similar UV crosslinking and gel electrophoresis experi-
ments were performed using point mutagenesis of the MDM2
C-terminal domain to further characterize the binding of MDM2
to XIAP IRES. The G448S (G446S in mouse form, conserved
asG448S in human)mutation has been previously demonstrated
to abolish the RNA binding of MDM2 (Elenbaas et al., 1996).
Thus, we generated this mutation in the 415–491 fragment
(415–491 D2), and another two mutations 415–491 D1 with
a S428G and 415–491 D3 with a L487S located in the first and
last 10 amino acids of the C-terminal RING domain (425–491),
respectively. These three mutant 415–491 fragments were fused
with GST and purified. Using the three mutants, RNA binding
assays showed that the G448S mutation greatly reduced the
specific XIAP IRES binding of MDM2, whereas the 415–491 frag-
ments with mutations S428G and L487S were still able to bind
XIAP IRES (Figure 5B).Cancer Cell 15, 363–375, May 5, 2009 ª2009 Elsevier Inc. 369
Cancer Cell
MDM2 Regulates XIAP in Cancer CellsBecause we found that the C-terminal RING domain of MDM2
binds to XIAP IRES, we also wished to determine what region on
the XIAP IRES is critical for MDM2 binding. We performed
a detailed study of theMDM2 binding site within XIAP IRES using
antisense mapping. The antisenses spanning the entire region of
the 162 nt XIAP IRES for mapping were shown in Figure 5C. We
observed that antisense A8 (34 to 49) containing the critical
polypyrimidine tract that is essential for XIAP IRES function (Hol-
cik et al., 2000) significantly disrupted the MDM2/XIAP IRES
complex formation (Figure 5D, lane 8). AntisenseA7 (44 to62),
to a lesser extent, inhibited the binding of MDM2 to XIAP IRES
(Figure 5D, lane 7). A combination of A8 and A7 completely
blocked the binding between MDM2 and XIAP IRES (Figure 5D,
lane 9). In concordance with these results, antisense mapping
for testing the binding between XIAP IRES and the MDM2 frag-
ment (415–491), resulted in binding to the same sequence from
34 to 62 (Figure 5E), a region that has been previously identi-
fied as RNP core binding site of XIAP IRES (Holcik et al., 2000).
Overexpression or Inhibition of MDM2 Increases
or Decreases Resistance to IR-Induced Apoptosis,
Respectively, through Regulation of XIAP
It is noted that in cancer cells treated with IR, XIAP is found to be
upregulated in the resistant cells, but comparatively downregu-
lated in the sensitive cells (Holcik et al., 2000). We further demon-
strate here that the fluctuation of XIAP levels in response to IR is
associated with MDM2. We found that following IR, XIAP protein
levels were upregulated in the MDM2-overexpressing SH-EP1
cell line, resulting in resistance to apoptosis, but downregulated
in the non-MDM2-overexpressing line SH-SY5Y, leading to
apoptosis (Figure S1).
We have further evaluated the possible impact of MDM2-
mediated upregulation of XIAP on IR resistance in isogenic cells.
In order to rule out the p53-dependent role ofMDM2 in regulating
apoptosis, we used p53-null ALL cell line EU-4 (expressing a very
low level of MDM2) and NB cell line LA1-55N (expressing a high
level of MDM2) as models (Figure S1A). We first transfected
MDM2 in EU-4 cells under control of Tet-on, and MDM2 expres-
sion was induced by adding doxycycline to the cell culture,
accompanied by an increase in XIAP expression (Figure 6A).
We tested the response to IR-induced apoptosis of cells with
different levels of MDM2 expression. As shown in Figures 6B
and 6C, cells cultured with 1 mg/ml doxycycline, which have
amaximumexpression ofMDM2 and XIAP, become significantly
resistant to IR as compared with the cells without doxycycline
(p < 0.01). To further confirm the role of upregulated XIAP
following MDM2 induction in IR resistance, we tested the effect
of IR treatment on resistant cells (with 1 mg/ml doxycycline) in the
presence of XIAP siRNA. Treatment of XIAP siRNA inhibits over
90% of endogenous XIAP (Figure 6D). Apoptosis resistance in
these cells is significantly reversed in the presence of XIAP
siRNA but not control siRNA during IR treatment (Figure 6E).
In contrast, we inhibited endogenous MDM2 expression using
siRNA in the MDM2-overexpressing LA1-55N, to determine
whether there were differences in XIAP regulation and sensitivity
to IR in these cells, with or without overexpression of MDM2. For
this, we used the pSUPER/MDM2 siRNA plasmid (pSUPER
MDM2, 1 in Figure 3D) to silence MDM2. Transfection of this
plasmid into the LA1-55N cells suppressed the endogenous370 Cancer Cell 15, 363–375, May 5, 2009 ª2009 Elsevier Inc.MDM2 protein (Figure 6F). We then investigated the kinetic
expression of the XIAP protein following IR treatment of LA1-
55N cells, transfected with either control siRNA or MDM2 siRNA
(clone 3). We found that IR induced upregulation of XIAP in the
LA1-55N control cells and downregulation of this protein in the
LA1-55N cells transfected with MDM2 siRNA. Consequently,
activation of caspases 9 and 3 occurred in the MDM2-silenced
LA1-55N, but not in control cells, following IR treatment (Fig-
ure 6G). Importantly, flow-cytometry assays showed that an
increased percentage of the LA1-55N/MDM2 siRNA cells treated
with IR were annexin V positive, as compared with control cells
(Figure 6H).
Blockade of MDM2/XIAP IRES Interaction Reduces
Resistance to IR-Induced Apoptosis
In order to convincingly demonstrate that it is the binding of
MDM2 to XIAP IRES that upregulates XIAP translation leading
to resistance to apoptosis, we evaluated whether block of the
MDM2/XIAP IRES interaction could inhibit XIAP induction in
MDM2-expressing cells following IR and reverse apoptosis
resistance. The antisense A7 and A8 as shown in Figures 5C
and 5D, which block the binding of MDM2 to XIAP IRES, were
used for the assay. The antisense A6 without activity to the
binding between MDM2 and XIAP IRES served as control. The
antisense used for transfection is phosphorothioate form that
is resistant to nuclease digestion in cells. Transfection and
reporter assays were performed in p53-null/MDM2-overex-
pressing LA1-5S cells using pbgal-xi-CAT plasmid in the pres-
ence or absence of the antisenses. We found that A7 and A8
reduced XIAP IRES-mediated CAT translation by approximately
10% and 20%, respectively, if provided at a concentration of
200 nM. When the combination of A7 and A8 (A7+8), which
completely blocks the binding between MDM2 and XIAP IRES
(Figures 5D and 5E), was used, an approximately 40% reduction
of CAT activity was achieved. At the same concentration, A6 did
not inhibit XIAP IRES-mediated CAT activity (Figure 7A). In addi-
tion, we tested the effect of the combination of antisense A7+8
on expression of endogenous XIAP in response to IR treatment.
When A7+8 were transfected into LA1-5S cells, they also signif-
icantly inhibited the IR-induced upregulation of endogenous
XIAP, as compared with the control (A6) antisense (Figure 7B).
Consequently, obvious reverse of resistance occurred in the
LA1-5S cells treated with A7+8, but not in the same cells treated
with A6, following IR exposure. As shown in Figure 7C, there was
a significant reduced survival of LA1-5S cells following IR treat-
ment in the presence of A7+8 at concentrations of 100 nM and
greater (p < 0.01) compared with that in the presence of A6, as
detected by water-soluble tetrazolium salt (WST) assay. Consis-
tent with these observations, a flow-cytometric apoptosis assay
showed that a increased percentage of LA1-5S cells treated with
IR plus A7+8 were annexin V positive at 24 hr after treatment
as compared with IR plus A6 (Figure 7D).
DISCUSSION
It is noted that overexpression of MDM2 independently of p53 is
involved in chemoresistance and tumor progression. However,
the mechanisms underlying all these activities are presently not
well defined. For example, it is not clear why many alternatively
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MDM2 Regulates XIAP in Cancer CellsFigure 6. Effect of MDM2-Mediated XIAP Translation on the Sensitivity of Cells to IR
(A) Dose-dependent induction of MDM2 by doxycycline in EU-4 cells transfected with Tet-controlled MDM2 plasmids followed by XIAP upregulation, detected by
western blot assay.
(B) Dose-dependent response to IR-induced apoptosis of EU-4/Tet-on/MDM2 cells in cultures with or without 1 mg/ml doxycycline. Cells were exposed to
different dose of IR for 48 hr, and apoptotic cells (annexin V positive) were detected by flow cytometry.
(C) Representative histograph of flow cytometry for detection of apoptosis in EU-4/Tet-on/MDM2 cells with different concentration of doxycycline and 10 Gy IR
for 48 hr.
(D) EU-4/Tet-on/MDM2 cells cultured with 1 mg/ml doxycycline were transfected with different concentrations of either XIAP siRNA or control siRNA for 48 hr.
Expression of endogenous XIAP was detected by western blotting.
(E) Time-course of apoptosis induced by IR in combination with either XIAP siRNA or control siRNA in EU-4/Tet-on/MDM2 cells with 1 mg/ml doxycycline. Cells
were treated with 10 Gy IR plus siRNA (100 nM) for the indicated time points, and apoptotic cells were detected by annexin V staining. Data represent the mean
percentage of annexin-V-positive cells from three independent experiments; bars, ± SD; *p < 0.01.
(F) Stable suppression of MDM2 in p53-null NB cell line LA1-55N by transfection of pSUPER MDM2 siRNA plasmid. The expression of MDM2 in LA1-55N cells
transfected with the pSUPER vector containing scrambled 19 nt (control) and in 4 clones transfected with pSUPER/MDM2 was detected by western blotting.
(G) Kinetic analyses of XIAP protein expression and concomitant activation of caspases 9 and 3 in LA1-55N cells transfected with either control siRNA or MDM2
siRNA, following 10 Gy IR.
(H) Time course of apoptosis induced by IR in LA1-55N/MDM2 siRNA and control cells. Cells were treated with 10 Gy IR for the indicated time points, and
apoptotic cells were detected by annexin V staining using flow cytometry.spliced forms of MDM2 lacking the N-terminal p53 binding
domain are overexpressed in a number of human cancers, or
exactly how transfection of p53-negative cells with these
MDM2 variants results in tumor promotion (Bartel et al., 2002;
Fridman et al., 2003). Several studies have noted that the
C-terminal RING domain of MDM2 regulates cell proliferation
via a p53-independent pathway (Argentini et al., 2000; Gu
et al., 2003). Here we show that the RING finger domain of
MDM2 interacted with XIAP IRES mRNA. Importantly, cyto-
plasmic redistribution of MDM2, which is modulated by IR,
causes a significant increase in XIAP protein levels in MDM2-
overexpressing cancer cells, resulting in resistance to apoptosis.
These results provide amechanismbywhichMDM2plays a p53-
independent role in regulating expression of the antiapoptoticfactor XIAP, which might be involved in resistance to cancer
treatment and disease progression.
A quite recent study showed that the RING finger domain of
MDM2 binds to p53mRNA in vivo, which increases p53 synthesis
(Candeias et al., 2008). Our results from the present study indicate
that MDM2 binds to the XIAP IRES mRNA in a manner similar to
binding to p53 mRNA and the RNA molecule, clone A, from the
SELEX procedure (Elenbaas et al., 1996): amino acids 425–491
of the RING domain of MDM2 are definitely necessary and suffi-
cient for XIAP IRES binding and the single point mutation G448S
abolished that binding. We have further demonstrated that dele-
tions of the first 10 amino acids or the last 11 amino acids of the
RING domain of MDM2disturb binding, suggesting that the entire
RING domain of MDM2 is necessary for XIAP IRES binding toCancer Cell 15, 363–375, May 5, 2009 ª2009 Elsevier Inc. 371
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MDM2 Regulates XIAP in Cancer CellsFigure 7. Effect of Blockage between MDM2 and XIAP IRES Interaction on XIAP Expression and IR-Induced Apoptosis
(A) LA1-5S cells were cotransfected with 5 mg pbgal-xi-CAT plasmid and increasing amounts of antisense (A6, A7, A8, and A7+8 as shown in Figure 5C). The
percentage of CAT activity (mean ± SD, calculated by normalizing with bgal activity) was given relative to a translation reaction performed in the absence of anti-
sense.
(B) The effect of antisense (A6 and A7+8) on IR-induced upregulation of endogenous XIAP in LA1-5S cells. Cells transfected with 200 nM A6 or A7+8 were
exposed to IR for the indicated time. The expression levels of XIAP, using actin as a control, were analyzed bywestern blotting (insert). Data in the graph represent
the relative expression of XIAP as compared with actin after this western blot was densitometrically scanned. *p < 0.01.
(C) LA1-5S cells were treatedwith 10Gy IR in the presence or absence of different dose of A6 or A7+8 as indicated. Cells were incubated for 48 hr, and cell viability
was determined by WST assay. Data represent the mean percentage (±SD) of cell survival from three independent experiments.
(D) Time course of apoptosis induced by IR in LA1-5S cells in the presence of A6 or A7+8 antisense (200 nM). Cells were treated with 10 Gy IR for the indicated
time points, and apoptotic cells were detected by annexin V staining using flow cytometry. Data represent the mean percentage of annexin-V positive cells from
three independent experiments; bars, ± SD; *p < 0.01.occur. This is also consistent with the results reported by Lai et al.
(1998), showing that the first 10 amino acids and the last 11 amino
acids of the RING domain of MDM2 are critical for binding to the
clone A RNA and a fragment (328–406) of human ribosomal
RNA. Interestingly, in comparing the nucleotide sequences
between clone A RNA and the MDM2-binding region of XIAP
IRES, no similar consensus sequences were identified in these
two RNAs. However, the predicted secondary structure of the
MDM2-binding regionwithinXIAP IRESwas similar to that of clone
A RNA. The structure of clone A RNA consists of a 30 stem-loop
(6 bp) and a 50 stem-loop (9 bp) that are connected with a large
single-stranded region of 13 nt (Elenbaas et al., 1996). A recent
study using enzymatic probing with RNase T1, RNase T2, and
RNase V1 proposed the XIAP IRES RNA secondary structure
model (Baird et al., 2007). An analogous structure to clone A RNA
was found in theMDM2-binding region of XIAP IRES that consists
of a 30 stem-loop (6 bp) connecting with a large single-stranded372 Cancer Cell 15, 363–375, May 5, 2009 ª2009 Elsevier Inc.region of 14 nt and a 50 9 bp incomplete stem-loop (2 bp
mismatches). Binding of MDM2 to both clone A RNA and the
XIAP IRES suggests that the specific secondary structure, but
not the primary nucleotide sequence, is critical for MDM2binding.
Importantly, we have demonstrated that cytoplasmic relocali-
zation of MDM2 is required to regulate XIAP translation. MDM2
is a nuclear phosphoprotein that is constitutively phosphorylated
under normal growth conditions, but becomes hypophosphory-
lated in response to IR (Meek and Knippschild, 2003; Blattner
et al., 2002; Okamoto et al., 2002). Our results indicate that
IR-induced hypophosphorylation (dephosphorylation) of MDM2
led to the translocation of this protein from the nucleus to the cyto-
plasm. In a previous report, it has been shown that the basal levels
of XIAP protein in growing/unstressed cells are similar (Holcik
et al., 2000). Consistent with this observation, our results showed
that five of six cultured cancer cell lines studied expressed similar
level of XIAP, no matter whether the cells expressed high or low
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nucleus under normal growth conditions is unable to regulate
XIAP translation, and that MDM2 overexpression in cultured or
growing cells does not necessarily relate with high levels of
XIAP. However, it was IR-induced dephosphorylation of MDM2
and its movement to the cytoplasm that influenced XIAP. We
demonstrated not only that upregulation of XIAP translation
following IR occurs in MDM2-overexpressing cells, but also that
transfection of a mutant MDM2 that localizes in the cytoplasm
significantly increased XIAP IRES activity. Our findings support
the notion that the subcellular compartmentalization of ITAFs
controls their trans-acting activity (Lewis et al., 2007).
The XIAP mRNA has both a short and long form of 50-UTR,
suggesting that XIAP translation is most likely regulated by
both cap-dependent (use of short 50-UTR) and cap-independent
(use of long 50-UTR containing IRES) mechanisms. Previous
studies demonstrate that during induced cellular stresses such
as exposure to IR, cap-dependent translation is rapidly inhibited
(Sheikh and Fornace, 1999; Spriggs et al., 2005), whereas cap-
independent (IRES-dependent) translation can persist for certain
antiapoptotic genes, including XIAP (Stoneley and Willis, 2004;
Hellen and Sarnow, 2001). Because the cap-independent trans-
lation of these anti-apoptotic genes under stress stimulation
might delay apoptosis, allowing time for the cells to repair any
damage that has incurred, it could lead to the development of
resistance to apoptosis. Because MDM2 is a stress-responsive
protein, the MDM2-mediated IRES-dependent translation of
XIAP might be critical for resistance to radiation therapy.
It is well known that genotoxic stress such as exposure to IR
activates p53, which regulates the transcription of many genes
controlling cell cycle checkpoints and apoptosis. Less study
has been done to evaluate genotoxic stress-regulated protein
translation, which also forms an important component of the total
cellular stress response (Kaufman, 1999). Previous studies have
claimed that the IRES-mediated translation of certain genes
(such as XIAP and HIAP2) following IR confers resistance of cells
to this stimulation (Lewis and Holcik, 2005). However, the mech-
anisms by which IRES-mediated translation contributes to
IR-induced resistance are unknown. Many efforts have been
made to discover the mediators involved in the modification of
IRES-regulated translation in cells. In the case of XIAP, the ITAF/
RNP (La, hnRNP C1/C2, and hnRNP A1) have been shown to
modify XIAP IRES function (Holcik and Korneluk, 2000; Holcik
et al., 2003; Lewis et al., 2007); however, the association of this
modification with cell stress-induced signaling remains unclear.
Results from the present study show that stress-induced
signaling regulated cytoplasmic translocation of MDM2, which
subsequently induced XIAP IRES activity, resulting in upregula-
tion of XIAP protein, conferring resistance to apoptosis. The
mechanistic insightsgenerated in thisstudywouldsuggesta func-
tional role for MDM2 in the regulation of XIAP IRES-dependent
translation during cellular stress and DNA damage, extending
our current understanding of resistance to radiotherapy in cancer.
EXPERIMENTAL PROCEDURES
Cells and Plasmids
Four human NB cell lines (SH-EP1, SH-SY5Y, LA1-55N, and LA1-5S) and two
human leukemiacell lines (EU-1andEU-4)were used in this study. TheplasmidsMDM2/166A or MDM2/166E were constructed by inserting the MDM2 cDNA
with mutations at serine 166 to either alanine (166A) or glutamic acid (166E)
into the pDsRed1-C1 vector. The wt and various C-terminal truncated and
mutated GST-tagged MDM2 constructs were generated by PCR and cloned
into thebacterial pGEXexpression vector. TheTet-Ongeneexpression systems
including pTet-On and its response (pTRE2hyg) plasmids were purchased from
Clontech (Palo Alto, CA). The human MDM2 cDNA was cloned into the pTRE2-
hyg at the BamHI restriction site. The pSUPER/MDM2 siRNA plasmids were
constructed by inserting several specific 19 ntMDM2 sequence into an expres-
sion plasmid, pSUPER-neo, purchased from OligoEngine (Seattle, WA). The
monocistronic plasmid pGL3-xp-xi was constructed by first inserting the XIAP
promoter (xp), which is a 1 kb DNA sequence 50-flank immediately upstream
of XIAPmRNA (Figure S1B), into the pGL3-basic vector, then inserting a 670 bp
cDNA fragment from the 50UTR of XIAP containing the 162-bp XIAP IRES (xi)
immediately downstream of xp. The bicistronic vector pbgal/CAT (containing
the XIAP IRES in either sense or antisense orientations) was kindly provided
by Dr. M. Holcik (University of Ottawa, Canada). The dicistronic vector pRL-xi-
FL was kindly provided by Dr. Richard E. Lloyd (Baylor College of Medicine).
Gene Transfection and Reporter Assay
To establish an MDM2-inducible model, both pTet-On and pTRE2hyg-MDM2
plasmids were stably transfected into EU-4 cells by electroporation to
generate a cell line EU-4/Tet-On/MDM2, where MDM2 expression was
induced by addition of doxycycline in the cell culture. For stable MDM2 siRNA
transfection, LA1-55N cells were transfected with pSUPER/MDM2 or pSUPER
containing a scrambled 19 nt (control) plasmid as described in detail online.
Transient transfection was performed to examine the effect of MDM2 on
XIAP IRES activity. Cells were cotransfected with various MDM2 expression
plasmids and either monocistronic or bicistronic and dicistronic XIAP IRES
reporter plasmids. The subcellular distribution of transfected MDM2 in
pDsRed1-C1 vector was detected by confocal microscopy. Luciferase activi-
ties were analyzed by Luciferase Assay Reagent II (Promega) and aMicroplate
Luminometer (Turner Designs). In the transfection of cells with bicistronic
plasmid, b-galactosidase (bgal) enzymatic activity was determined by the
chemiluminescent reporter gene assay system (Applied Biosystems, Bedford,
Massachusetts). CAT levels were determined using the CAT ELISA kit, accord-
ing to the protocol provided by the manufacturer (Roche Molecular Biochem-
icals, Indianapolis, IN).
UV Crosslinking and RNA Binding Assays
UVcrosslinking and immunoprecipitation assayswere performedas described
previously (Holcik et al., 2000). Briefly, the DNA templates for synthesis of the
XIAP IRES RNA probe (probe 1) and a control RNA probe (probe 2) from non-
IRES upstream 50-UTR of XIAP mRNA were generated by PCR using XIAP
IRES-specific primer pairs. A previously identified MDM2-binding RNA, clone
A RNA (probe 3) (Elenbaas et al., 1996), was used as a positive control. Inter-
nally labeled RNA probes were synthesized by in vitro transcription with T7
polymerase (MAXIScript T7 RNA polymerase kit, Ambion) in the presence of
[a-32P] UTP (Amersham). The cell extracts or purified MDM2 proteins were
mixed with 32P-labeled RNA probes. UV crosslinking of the RNA-protein
complexeswas performed and then resolved by 10%SDS-PAGE gel and visu-
alized by autoradiography.
XIAP mRNA was coimmunoprecipitated with MDM2 antibody from whole-
cell extracts by using the modified method, as described previously (Seto
et al., 1999), to detect the in vivo binding of MDM2 protein and XIAP mRNA
(see detailed description in Supplemental Experimental Procedures).
Antisense Mapping and Treatment
Mapping of the MDM2 binding site within the XIAP IRES by antisense oligonu-
cleotides was performed as described previously (Thomson et al., 1999).
Briefly, the internally 32P-labeled 162-nt XIAP IRES probe (probe 1) was mixed
with various antisense oligonucleotides spanning the entire 162 nt region. The
mixtures were incubated at 80C for 10 min, and allowed to cool gradually to
room temperature. The RNA probe-oligonucleotide hybrids were then incu-
bated either with rhMDM2 protein or with the GST-fused C-terminal RING
domain of MDM2 and analyzed. For antisense treatment in cells, 50–200 nM
phosphorothioate oligodenucleotides antisenses targeting the XIAP IRES
were delivered in the form of complex with Lipofectamine (Invitrogen).Cancer Cell 15, 363–375, May 5, 2009 ª2009 Elsevier Inc. 373
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Treatment
The protein synthesis and the half-life of XIAP were detected by pulse-chase
experiments, metabolic labeling, immunoprecipitation, and cycloheximide
treatment as described in Supplemental Experimental Procedures.
Polyribosome Profile Analysis
Linear sucrose gradient fractionation was carried out as described previously
(Feng et al., 1997). Briefly, cells treatedwith IR or transfectedwithMDM2-166A
or mock treated were lysed to isolate cytoplasmic extracts, followed by frac-
tionation on a 15%–45% (w/v) linear sucrose gradient. After centrifugation at
39,000 rpm in a SW41Ti rotor for 1 hr, 11 1 ml fractions were collected from
each gradient by upward replacement and the RNA in each fraction was
extracted and subjected to real-time RT-PCR as described in detail in Supple-
mental Experimental Procedures.
SUPPLEMENTAL DATA
The Supplemental Data include three figures and Supplemental Experimental
Procedures and can be found with this article online at http://www.cell.com/
cancer-cell/supplemental/S1535-6108(09)00077-4.
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